What is Aesyra?
Originating as a spin-off from the Federal Institute of Technology of Lausanne, Aesyra specializes in the development of sophisticated medical devices aimed at mitigating the effects of bruxism and improving overall sleep quality. The company's flagship innovation, the AesyBite, represents a significant leap forward in oral appliance therapy. By integrating compact, embedded sensors into a customizable dental device, Aesyra enables the precise collection of physiological metrics, allowing for more effective diagnosis and treatment. This technology addresses a significant gap in the current healthtech landscape, providing patients with a non-invasive, highly personalized tool for long-term protection and symptom management.
The company operates at the nexus of dental innovation and digital health, targeting a global demographic of individuals suffering from sleep bruxism. By focusing on home-based care, Aesyra is effectively decentralizing sleep medicine, reducing the reliance on clinical sleep labs while simultaneously increasing the granularity of patient data available to healthcare providers.
How much funding has Aesyra raised?
Aesyra has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2023): $3M with participation from Zurich Cantonal Bank and Supermoon Capital
Key Investors in Aesyra
Zurich Cantonal Bank
Zürcher Kantonalbank is a leading Swiss universal bank providing comprehensive financial services, including business financing and capital market transactions, with a strong focus on supporting regional innovation.
Supermoon Capital
Supermoon Capital is a specialized venture capital firm dedicated to investing in visionary founders and technologies that advance the science and practice of healthy sleep.
What's next for Aesyra?
With this major enterprise-level funding, Aesyra is well-positioned to accelerate its clinical validation processes and scale its manufacturing capabilities to meet rising demand. The strategic backing from specialized investors suggests a clear roadmap toward broader market penetration and the potential expansion of its product ecosystem. Future growth will likely focus on refining the AesyBite sensor suite and integrating these data streams into broader telehealth platforms, thereby enhancing the efficacy of remote patient monitoring. As the company transitions from its initial development phase to a more mature commercial stage, the focus will shift toward establishing strategic partnerships with dental networks and sleep clinics, solidifying its role as a leader in the burgeoning sleep health market.
See full Aesyra company page
